For instance, GWAS identified variants in the intron region of the fat mass and obesity-associated (FTO) gene, initially linked to type 2 diabetes, and later associated with obesity [57], metabolic syndrome [54], and subsequently, CVD [58]. This evidence concerns the gene FTO and metabolic syndrome.